Skip to main content
OpenTrials
Completed

NCT Number: NCT00568204

Study of Effectiveness of Mexyn-A

Atomised Methoxymethane-in-Aqua (MEXYN-A) a new topical self-chilled, non-steroidal, non-flammable, pressurised spray which embodies in one simultaneous application, most of the currently recognised and effective chemical, mechanical and thermal anti-pruritic therapies and hydrotherapy.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pruritus Pathological Conditions, Signs and Symptoms Signs and Symptoms Skin Diseases Skin Manifestations Skin and Connective Tissue Diseases

Age range

5 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Evangelical Synod Medical Centre

Cairo, Cairo Governorate, 11111, Egypt

About this study

The primary clinical endpoint was to establish MEXYN-A efficacy and safety in abolishing or reducing pruritus related to cutaneous diseases, insect bites and poison ivy, within few seconds of the application. The secondary endpoint was to measure the itch free period as a result of the new intervention.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients suffering from severe itching due to : Atopic Dermatitis, contact dermatitis, psoriasis, urticaria, xerosis, prickly heat, genital pruritus, chicken pox, aquagenic pruritus, lichen planus, poison ivey, insect bites.
  • Past experience with the use of at least one conventional medication for pruritus or conventional medication for the same disorder patients suffered.

Exclusion criteria

  • Patients who have taken any anti-pruritic drug during the month prior to participation.
  • Patients who have taken drugs for any reason for 2 days prior to participating in the study.

Treatment and study plan

Mexyn-A

Device

Atomised topical self-chilled pressurised spray

Other names: Clearitch, Itcharret, itchclear, Magicool-Plus

Primary outcomes

  1. Treating Pruritus

    Time frame: three days

Secondary outcomes

  1. measuring itch-free period after applying the new treatment, effect on sleep disturbance

    Time frame: three days

Sponsors and collaborators

Lead sponsor

Evangelical Synod Medical Centre

Other

Registry information

Official study title

Proof of Concept of MEXYN-A

Acronym: Mexyn-A

Important dates

Study start
2002
Study completion
2005
First posted
Dec 5, 2007
Registry last updated
Oct 17, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.